Avoro Capital Advisors LLC
Top Portfolio Positions
30 positions ·
$10,853,621,123 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
3,010,000 | $1,784,869,800 | 16.44% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
5,062,500 | $1,157,945,625 | 10.67% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
1,818,181 | $951,763,208 | 8.77% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
22,860,910 | $908,035,344 | 8.37% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
2,888,888 | $746,257,548 | 6.88% | |
| ARGX |
Argenx SE
Healthcare
|
1,000,000 | $730,250,000 | 6.73% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
10,699,999 | $670,889,937 | 6.18% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
7,474,747 | $622,571,677 | 5.74% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
12,222,222 | $491,699,991 | 4.53% | |
| CELC |
Celcuity Inc.
Healthcare
|
3,575,000 | $408,050,500 | 3.76% |
Portfolio Trend
25 quarters · across all stocks
Holdings in APLS
Shares Held
Position Value (USD)
23 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $491,699,991 | 12,222,222 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $307,022,216 | 12,222,222 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $276,588,883 | 12,222,222 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $211,566,662 | 12,222,222 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $267,299,995 | 12,222,222 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $390,011,104 | 12,222,222 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $320,444,441 | 11,111,111 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $426,222,217 | 11,111,111 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $653,111,104 | 11,111,111 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $665,111,104 | 11,111,111 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $422,666,662 | 11,111,111 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,012,222,212 | 11,111,111 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $732,888,881 | 11,111,111 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $549,418,750 | 10,625,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $691,537,500 | 10,125,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $443,382,100 | 9,805,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $480,154,500 | 9,450,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $404,506,640 | 8,555,555 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $164,800,000 | 5,000,000 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $49,934,400 | 1,515,000 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $63,530,536 | 1,005,230 | Shares | Sole | 2021-08-16 | |
| 2021-06-30 | $15,168,000 | 240,000 | Call | Sole | 2021-08-16 | |
| 2021-03-31 | $42,910,000 | 1,000,000 | Shares | Sole | 2021-05-17 | |
| No 13F history on record for this holder in this stock. | ||||||